Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
Stocks in this Quantisnow insightHealth Care
Historical context for HELP
Across the 27 sessions after earlier HELP headlines, the stock closed higher 18 times and lower 8 times, with a median move of 4.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | HELP | SPY |
|---|---|---|---|
| Oct 15, 2026 | Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors | +6.5% | +0.3% |
| Oct 8, 2026 | Helus Pharma to Host Investor Presentation on October 21, 2026 | +2.0% | -0.4% |
| Oct 1, 2026 | Helus Pharma Announces Completion of Legal Name Change | -3.1% | +0.2% |
| Sep 23, 2026 | Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change | -5.0% | -0.7% |
| Sep 22, 2026 | Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit | +0.4% | -0.0% |
| Sep 21, 2026 | Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026 | +10.4% | +1.6% |
Quantisnow market dataNASDAQ
HELP
Helus Pharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for HELP
Full HELP profile on Quantisnow Follow HELP and get a push notification the moment its next story breaks.